1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LIQUIDIA CORP
Liquidia Corp
XNAS: LQDA

Liquidia Corp Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hyperte...

Read More
42.63 0.35 (0.83%)
259.75% Gain from 52W Low
808.9K
XNAS Volume

XNAS 08 May, 2026 2:09 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The board meeting for Liquidia Corp is scheduled for today, for the purpose of Liquidia Corp First Quarter Earnings Results for 2026 See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
5.0 / 100
Momentum Score
Technically Bullish
72.0 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
51
1Yr Price target upside is 19%
9 analysts

19

S

6

W

5

O

0

T

SWOT Analysis

Liquidia Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..